Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy
Background Immune checkpoint inhibitors (ICIs) can produce specific immune-related adverse events including pneumonitis. The impact of ICI therapy on the severity of acute coronavirus infection symptomatology warrants further exploration.Case presentation We report a 65-year-old man diagnosed with s...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/1/e000898.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|